decreased tumor incidence_Myc<tm1Jlc>/Myc<tm1Jlc>

http://metadb.riken.jp/0002052I129S7SvEvBrdMyctm1JlcMyctm1JlcMyctm1Jlc

decreased tumor incidence_Myc<tm1Jlc>/Myc<tm1Jlc>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• myelocytomatosis oncogene
  http://metadb.riken.jp/db/mgi_rdf/MGI:97250

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Myc<tm1Jlc>/Myc<tm1Jlc>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Myc<tm1Jlc>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S7/SvEvBrd

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased tumor incidence
  http://purl.obolibrary.org/obo/MP_0002052

文献

http://purl.org/net/cito/citesAsAuthority

• Troy A. Baudino, et.al., c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression., Genes & development, 2002, 16
  http://rdf.ncbi.nlm.nih.gov/pubmed/12368264